{"cursor":"18612","size":15,"audio":[],"currentlang":"en","article":"{{Drugbox\n| Verifiedfields = changed verifiedrevid = 477241856 image = Adalimumab\n| structure.png\n\n\n| type = mab mab_type = mab source = u target = TNF alpha\n\n\n| tradename = Humira Drugs.com = MedlinePlus = a603010 pregnancy_AU = C\n| pregnancy_US = B legal_UK = POM legal_US = Rx-only routes_of_administration =\n| Subcutaneous\n\n\n| bioavailability = 64% (subcutaneous), 0% (oral) protein_bound = metabolism =\n| elimination_half-life = 10â20 days.\n\n\n| CAS_number_Ref = CAS_number = 331731-18-1 ATC_prefix = L04 ATC_suffix = AB04\n| ChemSpiderID_Ref = ChemSpiderID = NA PubChem = DrugBank_Ref = DrugBank =\n| DB00051 UNII_Ref = UNII = FYS6T7F842 KEGG_Ref = KEGG = D02597 ChEMBL_Ref =\n| ChEMBL = 1201580\n\n\n| C=6428 | H=9912 | N=1694 | O=1987 | S=46 molecular_weight = 144190.3 g/mol\n}} 'Adalimumab' (HUMIRA, AbbVie) is the third TNF inhibitor, after infliximab\nand etanercept, to be approved in the United States. Like infliximab and\netanercept, adalimumab binds to Tumor necrosis factor-alpha (TNFÎ±), preventing\nit from activating TNF receptors. Adalimumab was constructed from a fully human\nmonoclonal antibody, while infliximab is a mouse-human chimeric antibody and\netanercept is a TNF receptor-IgG fusion protein. TNFÎ± inactivation has proven to\nbe important in downregulating the inflammatory reactions associated with\nautoimmune diseases. As of 2008 adalimumab has been approved by the U.S. Food\nand Drug Administration (FDA) for the treatment of rheumatoid arthritis,\npsoriatic arthritis, ankylosing spondylitis, Crohn's disease, moderate to severe\nchronic psoriasis and juvenile idiopathic arthritis. Although only approved for\nulcerative colitis from late 2012 by the FDA in the disease's management, it has\nbeen used for several years in cases that have not responded to conventional\ntreatment at standard dosing for Crohn's Disease.\n\nHowever, because TNFÎ± is part of the immune system that protects the body from\ninfection, treatment with adalimumab may increase the risk of infections.\n\nHUMIRA (\"Human Monoclonal Antibody in Rheumatoid Arthritis\") is marketed in both\npreloaded 0.8 mL syringes and also in preloaded pen devices (called Humira Pen),\nboth injected subcutaneously, typically by the patient at home. It cannot be\nadministered orally because the digestive system would destroy the drug.\n\nAdalimumab was the first fully human monoclonal antibody drug approved by the\nFDA. It was derived from phage display, and was discovered through a\ncollaboration between BASF Bioresearch Corporation (Worcester, Massachusetts, a\nunit of BASF) and Cambridge Antibody Technology as D2E7, then further manufactured at BASF Bioresearch Corporation\nand developed by BASF Knoll (BASF Pharma) and, ultimately, manufactured and\nmarketed by Abbott Laboratories after the acquisition of BASF Pharma by Abbott.\n\nIn 2009, HUMIRA had over $5 billion in annual sales., htt-\np://www.abbott.com/static/content/microsite/annual_report/2006/humira.html\nwhilst in 2012 the drug reached $4.3 billion of sales in the US\nalone, http://www.drugs.com/stats/top100/2012/sales achieving $9.3\nbillion in worldwide sales for that year. http://www.abbott.com/press-release/abbott-reports-fourthquarter-and-\nfullyear-2012-results.htm\n","linknr":708,"url":"adalimumab","recorded":1376420409,"links":["/w/index.php?title=Adalimumab&action=edit","/w/index.php?title=Adalimumab&action=edit","//bits.wikimedia.org/favicon/wikipedia.ico","/w/opensearch_desc.php","//en.wikipedia.org/w/api.php?action=rsd","//creativecommons.org/licenses/by-sa/3.0/","/w/index.php?title=Special:RecentChanges&feed=atom","http://en.wikipedia.org/wiki/Adalimumab","//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&lang=en&modules=ext.gadget.DRN-wizard%2CReferenceTooltips%2Ccharinsert%2Cteahouse%7Cext.rtlcite%2Cwikihiero%7Cext.uls.nojs%7Cmediawiki.legacy.commonPrint%2Cshared%7Cmw.PopUpMediaTransform%7Cskins.vector&only=styles&skin=vector&*","//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&lang=en&modules=ext.visualEditor.viewPageTarget.noscript&only=styles&skin=vector&*","//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&lang=en&modules=site&only=styles&skin=vector&*","//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&lang=en&modules=startup&only=scripts&skin=vector&*","//bits.wikimedia.org/geoiplookup","//meta.wikimedia.org","#mw-navigation","#p-search","/wiki/Nomenclature_of_monoclonal_antibodies","/wiki/File:Adalimumab_structure.png","//upload.wikimedia.org/wikipedia/commons/thumb/d/d2/Adalimumab_structure.png/220px-Adalimumab_structure.png","/wiki/Monoclonal_antibody#Applications","/wiki/File:Engineered_monoclonal_antibodies.svg","/wiki/Monoclonal_antibody#Production","/wiki/Human","/wiki/Antigen","/wiki/TNF_alpha","/wiki/Trade_name","/wiki/American_Society_of_Health-System_Pharmacists","/wiki/Drugs.com","http://www.drugs.com/monograph/adalimumab.html","/wiki/MedlinePlus","http://www.nlm.nih.gov/medlineplus/druginfo/meds/a603010.html","/wiki/Pregnancy_category","/wiki/Australia","/wiki/United_States","/wiki/Regulation_of_therapeutic_goods","/wiki/Prescription_drug","/wiki/United_Kingdom","/wiki/Prescription_drug","/wiki/United_States","/wiki/Route_of_administration","/wiki/Subcutaneous_injection","/wiki/Bioavailability","/wiki/Per_os","/wiki/Biological_half-life","/wiki/CAS_registry_number","http://www.nlm.nih.gov/cgi/mesh/2009/MB_cgi?term=331731-18-1&rn=1","//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png","/wiki/Anatomical_Therapeutic_Chemical_Classification_System","/wiki/ATC_code_L04","http://www.whocc.no/atc_ddd_index/?code=L04AB04","/wiki/DrugBank","http://www.drugbank.ca/drugs/DB00051","/wiki/Unique_Ingredient_Identifier","http://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=FYS6T7F842","//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png","/wiki/KEGG","http://www.kegg.jp/entry/D02597","//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png","/wiki/ChEMBL","https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/CHEMBL1201580","//upload.wikimedia.org/wikipedia/commons/thumb/a/a2/X_mark.svg/7px-X_mark.svg.png","/wiki/Chemical_formula","/wiki/Carbon","/wiki/Hydrogen","/wiki/Nitrogen","/wiki/Oxygen","/wiki/Sulfur","/wiki/Molecular_mass","//upload.wikimedia.org/wikipedia/commons/thumb/a/a2/X_mark.svg/14px-X_mark.svg.png","/wiki/Wikipedia:WikiProject_Chemicals/Chembox_validation","//en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=477241856&page2=Adalimumab","/wiki/AbbVie","/wiki/TNF_inhibitor","/wiki/Infliximab","/wiki/Etanercept","/wiki/United_States","/wiki/Tumor_necrosis_factor-alpha","/wiki/Monoclonal_antibody","/wiki/Chimera_(protein)","/wiki/TNF","/wiki/Fusion_protein","/wiki/Downregulation","/wiki/Inflammation","/wiki/Autoimmune_disease","/wiki/Food_and_Drug_Administration","/wiki/Rheumatoid_arthritis","/wiki/Psoriatic_arthritis","/wiki/Ankylosing_spondylitis","/wiki/Crohn%27s_disease","/wiki/Psoriasis","/wiki/Juvenile_idiopathic_arthritis","/wiki/Ulcerative_colitis","/wiki/Syringe","/wiki/Autoinjector","/wiki/Injection_(medicine)","/wiki/Route_of_administration","/wiki/Digestive_system","/wiki/Phage_display","#cite_note-1","/wiki/BASF","/wiki/Cambridge_Antibody_Technology","#cite_note-Kempeni99-2","/wiki/Abbott_Laboratories","#cite_note-abbott.com-3","#cite_note-4","#cite_note-5","#History","#Notable_clinical_and_marketing_milestones","#Indication","#Rheumatoid_arthritis","#Psoriatic_arthritis","#Ankylosing_spondylitis","#Crohn.E2.80.99s_disease","#Ulcerative_colitis","#Plaque_psoriasis","#Juvenile_idiopathic_arthritis","#Safety","#Royalty_litigation","#Patent_litigation","#Similar_agents","#References","#External_links","/w/index.php?title=Adalimumab&action=edit&section=1","/w/index.php?title=Adalimumab&veaction=edit&section=1","/wiki/BASF","/wiki/Cambridge_Antibody_Technology","#cite_note-6","#cite_note-Kempeni99-2","#cite_note-7","/wiki/Abbott_Laboratories","#cite_note-8","#cite_note-9","/wiki/AbbVie","#cite_note-10","/w/index.php?title=Adalimumab&action=edit&section=2","/w/index.php?title=Adalimumab&veaction=edit&section=2","#cite_note-Kempeni99-2","/wiki/American_College_of_Rheumatology","#cite_note-11","#cite_note-abbott.com-3","#cite_note-12","/wiki/Food_and_Drug_Administration","#cite_note-abbott.com-3","#cite_note-abbott.com-3","#cite_note-abbott.com-3","#cite_note-13","#cite_note-abbott.com-3","#cite_note-abbott.com-3","#cite_note-14","#cite_note-15","#cite_note-16","#cite_note-17","/w/index.php?title=Adalimumab&action=edit&section=3","/w/index.php?title=Adalimumab&veaction=edit&section=3","/wiki/Tumor_necrosis_factors","/wiki/Infliximab","/wiki/Etanercept","/w/index.php?title=Adalimumab&action=edit&section=4","/w/index.php?title=Adalimumab&veaction=edit&section=4","/wiki/Rheumatoid_arthritis","/w/index.php?title=Adalimumab&action=edit&section=5","/w/index.php?title=Adalimumab&veaction=edit&section=5","#cite_note-18","/w/index.php?title=Adalimumab&action=edit&section=6","/w/index.php?title=Adalimumab&veaction=edit&section=6","/wiki/Ankylosing_spondylitis","#cite_note-19","/w/index.php?title=Adalimumab&action=edit&section=7","/w/index.php?title=Adalimumab&veaction=edit&section=7","#cite_note-Podolsky-20","/wiki/Crohn%27s_disease","/w/index.php?title=Adalimumab&action=edit&section=8","/w/index.php?title=Adalimumab&veaction=edit&section=8","/wiki/Ulcerative_colitis","#cite_note-21","#cite_note-22","/w/index.php?title=Adalimumab&action=edit&section=9","/w/index.php?title=Adalimumab&veaction=edit&section=9","/wiki/Plaque_psoriasis","/wiki/Phototherapy","#cite_note-23","/w/index.php?title=Adalimumab&action=edit&section=10","/w/index.php?title=Adalimumab&veaction=edit&section=10","#cite_note-medguide-24","/w/index.php?title=Adalimumab&action=edit&section=11","/w/index.php?title=Adalimumab&veaction=edit&section=11","/wiki/File:Components_of_a_Adalimumab-Humira_pen_-_annotated.jpg","//upload.wikimedia.org/wikipedia/en/thumb/2/2c/Components_of_a_Adalimumab-Humira_pen_-_annotated.jpg/225px-Components_of_a_Adalimumab-Humira_pen_-_annotated.jpg","/wiki/File:Components_of_a_Adalimumab-Humira_pen_-_annotated.jpg","//bits.wikimedia.org/static-1.22wmf12/skins/common/images/magnify-clip.png","/wiki/Autoinjector","/wiki/Tumor_necrosis_factors","#cite_note-25","/wiki/Infection","/wiki/Tuberculosis","/wiki/Lymphoma","#cite_note-26","/wiki/Cancer","/wiki/Liver","/wiki/Demyelinating","/wiki/Central_nervous_system","/wiki/Food_and_Drug_Administration","/wiki/Black_box_warning","/wiki/Tumor_necrosis_factors","#cite_note-medguide-24","#cite_note-medguide-24","/w/index.php?title=Adalimumab&action=edit&section=12","/w/index.php?title=Adalimumab&veaction=edit&section=12","/wiki/Cambridge_Antibody_Technology","/wiki/Abbott_Laboratories","/wiki/High_Court_of_Justice","/wiki/London","/wiki/Hugh_Laddie","#cite_note-27","#cite_note-28","#cite_note-29","/wiki/Medical_Research_Council_(UK)","#cite_note-30","/w/index.php?title=Adalimumab&action=edit&section=13","/w/index.php?title=Adalimumab&veaction=edit&section=13","#cite_note-31","/wiki/United_States_Court_of_Appeals_for_the_Federal_Circuit","#cite_note-32","/w/index.php?title=Adalimumab&action=edit&section=14","/w/index.php?title=Adalimumab&veaction=edit&section=14","/wiki/Infliximab","/wiki/Etanercept","/wiki/Certolizumab_pegol","/w/index.php?title=Adalimumab&action=edit&section=15","/w/index.php?title=Adalimumab&veaction=edit&section=15","#cite_ref-1","http://www.nature.com/nrd/journal/v2/n1/full/nrd984.html","/wiki/Digital_object_identifier","http://dx.doi.org/10.1038%2Fnrd984","/wiki/PubMed_Identifier","//www.ncbi.nlm.nih.gov/pubmed/12509759","#cite_ref-Kempeni99_2-0","#cite_ref-Kempeni99_2-1","#cite_ref-Kempeni99_2-2","http://ard.bmj.com/content/58/suppl_1/I70.full","/wiki/Digital_object_identifier","http://dx.doi.org/10.1136%2Fard.58.2008.i70","/wiki/PubMed_Central","//www.ncbi.nlm.nih.gov/pmc/articles/PMC1766582","/wiki/PubMed_Identifier","//www.ncbi.nlm.nih.gov/pubmed/10577977","#cite_ref-abbott.com_3-0","#cite_ref-abbott.com_3-1","#cite_ref-abbott.com_3-2","#cite_ref-abbott.com_3-3","#cite_ref-abbott.com_3-4","#cite_ref-abbott.com_3-5","#cite_ref-abbott.com_3-6","http://www.abbott.com/static/content/microsite/annual_report/2006/humira.html","#cite_ref-4","http://www.drugs.com/stats/top100/2012/sales","#cite_ref-5","http://www.abbott.com/press-release/abbott-reports-fourthquarter-and-fullyear-2012-results.htm","#cite_ref-6","http://www.cambridgeantibody.com/home/news_and_resources/news_archive/2003/cambridge_antibody_technology__humira","#cite_ref-7","/wiki/Digital_object_identifier","http://dx.doi.org/10.1038%2Fnbt0994-899","/wiki/PubMed_Identifier","//www.ncbi.nlm.nih.gov/pubmed/7521646","#cite_ref-8","http://www2.basf.us/corporate/news2000/newsknoll_pharma_121500.html","#cite_ref-9","http://www.abbott.com/press-release/abbott-completes-separation-of-researchbased-pharmaceuticals-business.htm","#cite_ref-10","http://www.abbvie.com/products/home.html","#cite_ref-11","http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=/www/story/11-12-2001/0001613559&EDATE=","#cite_ref-12","http://ard.bmj.com/content/61/suppl_2/ii70.full","/wiki/Digital_object_identifier","http://dx.doi.org/10.1136%2Fard.61.suppl_2.ii70","/wiki/PubMed_Central","//www.ncbi.nlm.nih.gov/pmc/articles/PMC1766697","/wiki/PubMed_Identifier","//www.ncbi.nlm.nih.gov/pubmed/12379628","#cite_ref-13","http://www.thefreelibrary.com/Eisai+Submits+New+Drug+Application+for+Rheumatoid+Arthritis+Drug...-a0140148456","#cite_ref-14","http://www.abbott.com/static/content/microsite/annual_report/2007/overview_milestones.html","#cite_ref-15","http://www.abbott.com/global/url/pressRelease/en_US/60.5:5/Press_Release_0439.htm","#cite_ref-16","http://www.abbott.com/global/url/pressRelease/en_US/60.5:5/Press_Release_0737.htm","#cite_ref-17","http://www.sciencedaily.com/releases/2012/03/120316101632.htm","#cite_ref-18","/wiki/PubMed_Identifier","//www.ncbi.nlm.nih.gov/pubmed/12884458","#cite_ref-19","http://www.humira.com/as/default.aspx","#cite_ref-Podolsky_20-0","http://content.nejm.org/cgi/content/extract/347/6/417","/wiki/Digital_object_identifier","http://dx.doi.org/10.1056%2FNEJMra020831","/wiki/PubMed_Identifier","//www.ncbi.nlm.nih.gov/pubmed/12167685","#cite_ref-21","http://informahealthcare.com/doi/abs/10.1517/14712598.2011.541435","/wiki/Digital_object_identifier","http://dx.doi.org/10.1517%2F14712598.2011.541435","/wiki/PubMed_Identifier","//www.ncbi.nlm.nih.gov/pubmed/21133817","#cite_ref-22","http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm321650.htm","/wiki/Food_and_Drug_Administration","#cite_ref-23","/wiki/Digital_object_identifier","http://dx.doi.org/10.2165%2F0128071-200910010-00008","/wiki/PubMed_Identifier","//www.ncbi.nlm.nih.gov/pubmed/19170412","#cite_ref-medguide_24-0","#cite_ref-medguide_24-1","#cite_ref-medguide_24-2","http://www.rxabbott.com/pdf/humira_medguide.pdf","#cite_ref-25","#cite_ref-26","http://www.fdable.com/advanced_aers_query/c92ac23d3e2c43d72f398360cda8ce5c","#cite_ref-27","http://www.chandb.com/MBE/assessment_041220_CaT_Abbott_judgement_summary.doc","#cite_ref-28","http://news.bbc.co.uk/1/hi/business/4112235.stm","#cite_ref-29","http://www.telegraph.co.uk/finance/2924694/Drug-maker-CAT-surges-after-royalty-settlement.html","#cite_ref-30","http://www.mrctechnology.org/resources/PR/MRC_Humira_PRESS_RELEASE.pdf","#cite_ref-31","http://www.bloomberg.com/apps/news?pid=newsarchive&sid=ai9qZo._7.sw","#cite_ref-32","/w/index.php?title=Adalimumab&action=edit&section=16","/w/index.php?title=Adalimumab&veaction=edit&section=16","http://www.humira.com","http://www.myhumira.com","http://www.google.com/views?hl=en&safe=off&q=humira++view%3Atimeline&btnG=Search","http://www.drugcite.com?q=HUMIRA","/wiki/Template:Immunosuppressants","/wiki/Template_talk:Immunosuppressants","//en.wikipedia.org/w/index.php?title=Template:Immunosuppressants&action=edit","/wiki/Immunomodulator","/wiki/Immunosuppressive_drug","/wiki/Immunosuppressant","/wiki/ATC_code_L04","/wiki/Antimetabolite","/wiki/Purine_synthesis_inhibitor","/wiki/Azathioprine","/wiki/Mycophenolic_acid","/wiki/Pyrimidine_synthesis_inhibitor","/wiki/Leflunomide","/wiki/Teriflunomide","/wiki/Antifolate","/wiki/Methotrexate","/wiki/Macrolide","/wiki/Interleukin_2","/wiki/FKBP","/wiki/Cyclophilin","/wiki/Calcineurin","/wiki/Tacrolimus","/wiki/Ciclosporin","/wiki/Pimecrolimus","/wiki/Abetimus","/wiki/Gusperimus","/wiki/Thalidomide","/wiki/Lenalidomide","/wiki/Interleukin_1_receptor_antagonist","/wiki/Anakinra","/wiki/Mammalian_target_of_rapamycin","/wiki/Sirolimus","/wiki/Everolimus","/wiki/Ridaforolimus","/wiki/Temsirolimus","/wiki/Umirolimus","/wiki/Zotarolimus","/wiki/Antibody","/wiki/Monoclonal_antibodies","/wiki/Complement_component_5","/wiki/Eculizumab","/wiki/TNF_inhibitor","/wiki/Afelimomab","/wiki/Certolizumab_pegol","/wiki/Golimumab","/wiki/Infliximab","/wiki/Nerelimomab","/wiki/Interleukin_5","/wiki/Mepolizumab","/wiki/Immunoglobulin_E","/wiki/Omalizumab","/wiki/Interferon","/wiki/Faralimomab","/wiki/Interleukin_6","/wiki/Elsilimomab","/wiki/Interleukin_12","/wiki/Interleukin_23","/wiki/Lebrikizumab","/wiki/Ustekinumab","/wiki/CD3_(immunology)","/wiki/Muromonab-CD3","/wiki/Otelixizumab","/wiki/Teplizumab","/wiki/Visilizumab","/wiki/CD4","/wiki/Clenoliximab","/wiki/Keliximab","/wiki/Zanolimumab","/wiki/CD11a","/wiki/Efalizumab","/wiki/CD18","/wiki/Erlizumab","/wiki/CD20","/wiki/Afutuzumab","/wiki/Rituximab","/wiki/Ocrelizumab","/wiki/Pascolizumab","/wiki/CD23","/wiki/Gomiliximab","/wiki/Lumiliximab","/wiki/CD40_(protein)","/wiki/Teneliximab","/wiki/Toralizumab","/wiki/L-selectin","/wiki/Aselizumab","/wiki/CD80","/wiki/Galiximab","/wiki/Basigin","/wiki/Gavilimomab","/wiki/CD154","/wiki/Ruplizumab","/wiki/Belimumab","/wiki/CTLA-4","/wiki/Ipilimumab","/wiki/Tremelimumab","/wiki/Chloramphenicol_acetyltransferase","/wiki/Bertilimumab","/wiki/Lerdelimumab","/wiki/Metelimumab","/wiki/Integrin","/wiki/Natalizumab","/wiki/Interleukin-6_receptor","/wiki/Tocilizumab","/wiki/Lymphocyte_function-associated_antigen_1","/wiki/Odulimomab","/wiki/IL-2_receptor","/wiki/Basiliximab","/wiki/Daclizumab","/wiki/Inolimomab","/wiki/T_cell","/wiki/Zolimomab_aritox","/wiki/Atorolimumab","/wiki/Cedelizumab","/wiki/Fontolizumab","/wiki/Maslimomab","/wiki/Morolimumab","/wiki/Pexelizumab","/wiki/Reslizumab","/wiki/Rovelizumab","/wiki/Siplizumab","/wiki/Talizumab","/wiki/Telimomab_aritox","/wiki/Vapaliximab","/wiki/Vepalimomab","/wiki/Polyclonal_antibodies","/wiki/Anti-thymocyte_globulin","/wiki/Anti-lymphocyte_globulin","/wiki/Fusion_protein","/wiki/CTLA-4","/wiki/Abatacept","/wiki/Belatacept","/wiki/TNF_inhibitor","/wiki/Etanercept","/wiki/Pegsunercept","/wiki/Aflibercept","/wiki/Alefacept","/wiki/Rilonacept","/wiki/Template:Medicine_navs","/wiki/Lymphocyte","/wiki/Template:Lymphocytes","/wiki/Template:Lymphocytic_immune_system","/wiki/Template:Autoantigens","/wiki/Template:Autoantibodies","/wiki/Template:Complement_system","/wiki/Template:Immunoglobulin_superfamily_immune_receptors","/wiki/Template:Lymphoid_and_complement_immunodeficiency","/wiki/Template:Immunoproliferative_immunoglobulin_disorders","/wiki/Template:Hypersensitivity_and_autoimmune_diseases","/wiki/Template:Lymphoid_malignancy","/wiki/Template:Immunologic_techniques_and_tests","/wiki/Template:Immunostimulants","/wiki/Template:Immunosuppressants","/wiki/Template:Monoclonals_for_immune_system","/wiki/Template_talk:Monoclonals_for_immune_system","//en.wikipedia.org/w/index.php?title=Template:Monoclonals_for_immune_system&action=edit","/wiki/Monoclonal_antibodies","/wiki/Immune_system","/wiki/Immune_system","/wiki/Immunosuppression","/wiki/Anifrolumab","/wiki/Atorolimumab","/wiki/Belimumab","/wiki/Brodalumab","/wiki/Carlumab","/wiki/Dupilumab","/wiki/Eldelumab","/wiki/Fresolimumab","/wiki/Golimumab","/wiki/Lerdelimumab","/wiki/Lirilumab","/wiki/Mavrilimumab","/wiki/Metelimumab","/wiki/Morolimumab","/wiki/Namilumab","/wiki/Oxelumab","/wiki/Placulumab","/wiki/Sarilumab","/wiki/Sifalimumab","/wiki/Tabalumab","/wiki/Ipilimumab","/wiki/Tremelimumab","/wiki/Nivolumab","/wiki/Urelumab","/wiki/Bertilimumab","/wiki/Zanolimumab","/wiki/Afelimomab","/wiki/Elsilimomab","/wiki/Faralimomab","/wiki/Gavilimomab","/wiki/Inolimomab","/wiki/Maslimomab","/wiki/Nerelimomab","/wiki/Odulimomab","/wiki/Telimomab_aritox","/wiki/Vepalimomab","/wiki/Zolimomab_aritox","/wiki/Chimeric_antibody","/wiki/Basiliximab","/wiki/Clenoliximab","/wiki/Galiximab","/wiki/Gomiliximab","/wiki/Infliximab","/wiki/Keliximab","/wiki/Lumiliximab","/wiki/Priliximab","/wiki/Teneliximab","/wiki/Vapaliximab","/wiki/Humanized_antibody","/wiki/Aselizumab","/wiki/Apolizumab","/wiki/Benralizumab","/wiki/Cedelizumab","/wiki/Certolizumab_pegol","/wiki/Daclizumab","/wiki/Eculizumab","/wiki/Efalizumab","/wiki/Epratuzumab","/wiki/Erlizumab","/wiki/Etrolizumab","/wiki/Fontolizumab","/wiki/Itolizumab","/wiki/Lambrolizumab","/wiki/Lampalizumab","/wiki/Ligelizumab","/wiki/Mepolizumab","/wiki/Mogamulizumab","/wiki/Natalizumab","/wiki/Ocrelizumab","/wiki/Omalizumab","/wiki/Ozoralizumab","/wiki/Pascolizumab","/wiki/Pateclizumab","/wiki/Pexelizumab","/wiki/Pidilizumab","/wiki/PRO_140","/wiki/Reslizumab","/wiki/Rontalizumab","/wiki/Rovelizumab","/wiki/Ruplizumab","/wiki/Quilizumab","/wiki/Samalizumab","/wiki/Siplizumab","/wiki/Talizumab","/wiki/Teplizumab","/wiki/Tocilizumab","/wiki/Toralizumab","/wiki/Tregalizumab","/wiki/Vatelizumab","/wiki/Vedolizumab","/wiki/Visilizumab","/wiki/TGN1412","/wiki/Ibalizumab","/wiki/Otelixizumab","/wiki/Interleukin","/wiki/Briakinumab","/wiki/Canakinumab","/wiki/Fezakinumab","/wiki/Guselkumab","/wiki/Secukinumab","/wiki/Sirukumab","/wiki/Tralokinumab","/wiki/Ustekinumab","/wiki/Anrukinzumab","/wiki/Clazakizumab","/wiki/Enokizumab","/wiki/Gevokizumab","/wiki/Ixekizumab","/wiki/Lebrikizumab","/wiki/Olokizumab","/wiki/Perakizumab","/wiki/Tildrakizumab","/wiki/Lesion","/wiki/Besilesomab","/wiki/Technetium_(99mTc)_fanolesomab","/wiki/Lemalesomab","/wiki/Technetium_(99mTc)_sulesomab","/wiki/List_of_World_Health_Organization_Essential_Medicines","/wiki/List_of_withdrawn_drugs","/wiki/Clinical_trial","/wiki/Clinical_trial#Phase_III","/wiki/Clinical_trial#Phase_II","/wiki/Template:Medicine_navs","/wiki/Lymphocyte","/wiki/Template:Lymphocytes","/wiki/Template:Lymphocytic_immune_system","/wiki/Template:Autoantigens","/wiki/Template:Autoantibodies","/wiki/Template:Complement_system","/wiki/Template:Immunoglobulin_superfamily_immune_receptors","/wiki/Template:Lymphoid_and_complement_immunodeficiency","/wiki/Template:Immunoproliferative_immunoglobulin_disorders","/wiki/Template:Hypersensitivity_and_autoimmune_diseases","/wiki/Template:Lymphoid_malignancy","/wiki/Template:Immunologic_techniques_and_tests","/wiki/Template:Immunostimulants","/wiki/Template:Immunosuppressants","//en.wikipedia.org/w/index.php?title=Special:CentralAutoLogin/start&type=1x1&from=enwiki","http://en.wikipedia.org/w/index.php?title=Adalimumab&oldid=559621238","/wiki/Help:Category","/wiki/Category:TNF_inhibitors","/wiki/Category:Monoclonal_antibodies","/wiki/Category:Immunosuppressants","/wiki/Category:Chemical_compounds_which_do_not_have_a_ChemSpiderID","/wiki/Category:Articles_with_changed_EBI_identifier","/wiki/Category:Drugboxes_which_contain_changes_to_verified_fields","/w/index.php?title=Special:UserLogin&returnto=Adalimumab&type=signup","/w/index.php?title=Special:UserLogin&returnto=Adalimumab","/wiki/Adalimumab","/wiki/Talk:Adalimumab","#","/wiki/Adalimumab","/w/index.php?title=Adalimumab&action=edit","/w/index.php?title=Adalimumab&veaction=edit","/w/index.php?title=Adalimumab&action=history","#","/w/index.php","//bits.wikimedia.org/static-1.22wmf12/skins/vector/images/search-ltr.png?303-4","/wiki/Main_Page","/wiki/Main_Page","/wiki/Portal:Contents","/wiki/Portal:Featured_content","/wiki/Portal:Current_events","/wiki/Special:Random","https://donate.wikimedia.org/wiki/Special:FundraiserRedirector?utm_source=donate&utm_medium=sidebar&utm_campaign=C13_en.wikipedia.org&uselang=en","/wiki/Help:Contents","/wiki/Wikipedia:About","/wiki/Wikipedia:Community_portal","/wiki/Special:RecentChanges","//en.wikipedia.org/wiki/Wikipedia:Contact_us","/wiki/Special:WhatLinksHere/Adalimumab","/wiki/Special:RecentChangesLinked/Adalimumab","/wiki/Wikipedia:File_Upload_Wizard","/wiki/Special:SpecialPages","/w/index.php?title=Adalimumab&oldid=559621238","/w/index.php?title=Adalimumab&action=info","//www.wikidata.org/wiki/Q348260","/w/index.php?title=Special:Cite&page=Adalimumab&id=559621238","/w/index.php?title=Special:Book&bookcmd=book_creator&referer=Adalimumab","/w/index.php?title=Special:Book&bookcmd=render_article&arttitle=Adalimumab&oldid=559621238&writer=rl","/w/index.php?title=Adalimumab&printable=yes","//ar.wikipedia.org/wiki/%D8%A3%D8%AF%D8%A7%D9%84%D9%8A%D9%85%D9%88%D9%85%D8%A7%D8%A8","//ca.wikipedia.org/wiki/Adalimumab","//de.wikipedia.org/wiki/Adalimumab","//es.wikipedia.org/wiki/Adalimumab","//fr.wikipedia.org/wiki/Adalimumab","//it.wikipedia.org/wiki/Adalimumab","//nl.wikipedia.org/wiki/Adalimumab","//ja.wikipedia.org/wiki/%E3%82%A2%E3%83%80%E3%83%AA%E3%83%A0%E3%83%9E%E3%83%96","//pl.wikipedia.org/wiki/Adalimumab","//pt.wikipedia.org/wiki/Adalimumabe","//fi.wikipedia.org/wiki/Adalimumabi","//tr.wikipedia.org/wiki/Adalimumab","#","//www.wikidata.org/wiki/Q348260#sitelinks-wikipedia","//en.wikipedia.org/wiki/Wikipedia:Text_of_Creative_Commons_Attribution-ShareAlike_3.0_Unported_License","//creativecommons.org/licenses/by-sa/3.0/","//wikimediafoundation.org/wiki/Terms_of_Use","//wikimediafoundation.org/wiki/Privacy_policy","//www.wikimediafoundation.org/","//wikimediafoundation.org/wiki/Privacy_policy","/wiki/Wikipedia:About","/wiki/Wikipedia:General_disclaimer","//en.wikipedia.org/wiki/Wikipedia:Contact_us","//en.m.wikipedia.org/wiki/Adalimumab","//wikimediafoundation.org/","//bits.wikimedia.org/images/wikimedia-button.png","//www.mediawiki.org/","//bits.wikimedia.org/static-1.22wmf12/skins/common/images/poweredby_mediawiki_88x31.png","//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&lang=en&modules=site&only=scripts&skin=vector&*"],"instances":["medicine","uk","protein"],"pdf":["http://www.rxabbott.com/pdf/humira_medguide.pdf","http://www.mrctechnology.org/resources/PR/MRC_Humira_PRESS_RELEASE.pdf"],"categories":["TNF inhibitors","Monoclonal antibodies","Immunosuppressants"],"headings":["History","Notable clinical and marketing milestones","Indication","Safety","Royalty litigation","Patent litigation","Similar agents","References","External links"],"image":["//upload.wikimedia.org/wikipedia/commons/thumb/d/d2/Adalimumab_structure.png/220px-Adalimumab_structure.png","//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png","//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png","//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png","//upload.wikimedia.org/wikipedia/commons/thumb/a/a2/X_mark.svg/7px-X_mark.svg.png","//upload.wikimedia.org/wikipedia/commons/thumb/a/a2/X_mark.svg/14px-X_mark.svg.png","//upload.wikimedia.org/wikipedia/en/thumb/2/2c/Components_of_a_Adalimumab-Humira_pen_-_annotated.jpg/225px-Components_of_a_Adalimumab-Humira_pen_-_annotated.jpg","//bits.wikimedia.org/static-1.22wmf12/skins/common/images/magnify-clip.png","//en.wikipedia.org/w/index.php?title=Special:CentralAutoLogin/start&type=1x1&from=enwiki","//bits.wikimedia.org/static-1.22wmf12/skins/vector/images/search-ltr.png?303-4","//bits.wikimedia.org/images/wikimedia-button.png","//bits.wikimedia.org/static-1.22wmf12/skins/common/images/poweredby_mediawiki_88x31.png"],"tags":[["chimera","protein"],["injection","medicine"],["medical_research_council","uk"]],"members":["injection","medical_research_council","chimera"],"related":["TNF_alpha","Subcutaneous_injection","Per_os","AbbVie","TNF_inhibitor","Infliximab","Etanercept","United_States","Tumor_necrosis_factor-alpha","Monoclonal_antibody","Chimera_(protein)","TNF","Fusion_protein","Downregulation","Inflammation","Autoimmune_disease","Food_and_Drug_Administration","Rheumatoid_arthritis","Psoriatic_arthritis","Ankylosing_spondylitis","Crohn's_disease","Psoriasis","Juvenile_idiopathic_arthritis","Ulcerative_colitis","Syringe","Autoinjector","Injection_(medicine)","Route_of_administration","Digestive_system","Phage_display","BASF","Cambridge_Antibody_Technology","Abbott_Laboratories","BASF","Cambridge_Antibody_Technology","Abbott_Laboratories","AbbVie","American_College_of_Rheumatology","Food_and_Drug_Administration","Tumor_necrosis_factors","Infliximab","Etanercept","Rheumatoid_arthritis","Ankylosing_spondylitis","Crohn's_disease","Ulcerative_colitis","Plaque_psoriasis","Phototherapy","Tumor_necrosis_factors","Infection","Tuberculosis","Lymphoma","Cancer","Liver","Demyelinating","Central_nervous_system","Food_and_Drug_Administration","Black_box_warning","Tumor_necrosis_factors","Cambridge_Antibody_Technology","Abbott_Laboratories","High_Court_of_Justice","London","Hugh_Laddie","Medical_Research_Council_(UK)","United_States_Court_of_Appeals_for_the_Federal_Circuit","Infliximab","Etanercept","Certolizumab_pegol"]}